Open AccessEfficacy and safety of autologous bone marrow derived hematopoietic stem cell transplantation in patients with type 2 DM: A 15 months follow-up study
Author(s) -
Anil Bhansali,
Vimal Upreti,
Rama Walia,
Vivek Gupta,
Shobhit Bhansali,
Ratti Ram Sharma,
Sandeep Grover,
Neelam Marwaha,
Niranjan Khandelwal
Publication year - 2014
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.140257
Subject(s) - medicine , adverse effect , pioglitazone , stem cell , insulin , diabetes mellitus , metformin , transplantation , hematopoietic stem cell transplantation , glucose homeostasis , bone marrow , gastroenterology , surgery , type 2 diabetes , oncology , endocrinology , insulin resistance , biology , genetics
there are dearths of studies describing the effect of autologous bone marrow derived stem cell transplantation (ABMSCT) through targeted approach in Type 2 Diabetes Mellitus. This study reports the efficacy and safety of super-selective injection of ABMSCT in T2DM.